Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity and can be used to study leukemia.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 73,000 |
5 mg | 在庫あり | ¥ 175,000 |
10 mg | 在庫あり | ¥ 243,500 |
25 mg | 在庫あり | ¥ 342,000 |
50 mg | 在庫あり | ¥ 457,000 |
100 mg | 在庫あり | ¥ 569,500 |
説明 | Ziftomenib (KO-539) is an inhibitor of menin-MLL interaction with antitumor activity and can be used to study leukemia. |
In vitro | Zifomenib acts highly selective in MLL-r and NPM1mut acute myeloid leukemia and synergizes with a variety of targeted drugs in vitro[1]. |
別名 | KO-539 |
分子量 | 717.871 |
分子式 | C33H42F3N9O2S2 |
CAS No. | 2134675-36-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (111.44 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ziftomenib 2134675-36-6 Chromatin/Epigenetic Histone Methyltransferase KO 539 KO539 KO-539 Inhibitor inhibitor inhibit